KPMA to oppose against positive list system.

Published: 2006-05-10 07:00:00

Updated: 2006-05-10 07:00:00

The KPMA said that the MOHW's new drug pricing system called "Positive List System" might cause to impose rather the patient's more payment burdens abreast the NHI security setback, and therefore expressed an opposing position against the new system, claiming that it raises a lot of problems such...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK